Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 3/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.41 |
| ▸ | VCP | P55072 | 1/20 | 0.40 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.40 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.40 |
| ▸ | NAMPT | P43490 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8009648 | 0.92 | PTAFR (0.44) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7980003 | 0.92 | PTAFR (0.44) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7978613 | 0.92 | PTAFR (0.44) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7979922 | 0.91 | PTAFR (0.43) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7976660 | 0.91 | PTAFR (0.43) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7976664 | 0.91 | PTAFR (0.43) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL8016580 | 0.91 | ADAMTS4 (0.45) | PTAFRADAMTS4NAMPTHTTSMN1; SMN2 | |
| SCHEMBL7983208 | 0.91 | ADAMTS4 (0.45) | PTAFRADAMTS4NAMPTHTTSMN1; SMN2 | |
| SCHEMBL7966529 | 0.90 | PTAFR (0.44) | PTAFRADAMTS4CYP11B1NAMPTHTT | |
| SCHEMBL7966525 | 0.90 | PTAFR (0.44) | PTAFRADAMTS4CYP11B1NAMPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6300352-B1 | FOR THERAPY OF ASTHMA | ASTRAZENECA AB (SE) | 2001-10-09 | — | — | US | claimed |
| EP-0971892-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Astra Pharmaceuticals Limited (GB) | 2000-01-19 | — | — | EP | claimed |
| WO-1998042670-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ASTRA PHARMACEUTICALS LTD. (GB) | 1998-10-01 | — | — | WO | claimed |
| US-6300352-B1 | FOR THERAPY OF ASTHMA | ASTRAZENECA AB (SE) | 2001-10-09 | — | — | US | disclosed |
| EP-0971892-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Astra Pharmaceuticals Limited (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042670-A1 | NOVEL PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ASTRA PHARMACEUTICALS LTD. (GB) | 1998-10-01 | — | — | WO | disclosed |